Literature DB >> 11013607

[Whole-body MRA on a rolling table platform (AngioSURF)].

S G Ruehm1, M Goyen, H H Quick, M Schlepütz, H Schlepütz, S Bosk, J Barkhausen, M E Ladd, J F Debatin.   

Abstract

PURPOSE: Development of a technique for whole-body MR angiography based on a rolling table platform and integration of a surface coil.
MATERIAL AND METHODS: The developed rolling table platform AngioSURF (System for Unlimited Rolling Field-of-view) with integrated surface coil can be mounted on top of the original patient table of a Siemens Symphony System. Data acquisition was performed with a standard body array surface coil. The system was tested on three volunteers and one patient with angiographically documented vascular pathology. Data acquisition was performed with a 3D-FLASH-sequence (TR/TE 2.1/0.7 ms, flip angle: 20 degrees, FOV 40 x 40 cm, 80 partitions, matrix 512 x 420 with zero interpolation). Five data sets were collected in immediate succession during continuous injection of a paramagnetic contrast agent. Time of acquisition per data set was 10 seconds. Table repositioning was performed manually within 3 seconds. Thus the total acquisition time amounted to 72 seconds.
RESULTS: No problems with handling occurred in any of the four cases. The excellent image quality enables detailed assessment of the displayed vascular territories.
CONCLUSIONS: The rolling table platform with integrated surface coil (AngioSURF) allows diagnostic display of the arterial vascular system from supraaortic vessels to the distal trifurcation arteries in only 72 seconds.

Entities:  

Mesh:

Year:  2000        PMID: 11013607     DOI: 10.1055/s-2000-7177

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  13 in total

1.  Skeletal muscle metastasis from uterine leiomyosarcoma.

Authors:  J M O'Brien; D D Brennan; D H Taylor; D P Holloway; B Hurson; J C O'Keane; S J Eustace
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199

2.  [Cardiovascular whole-body MRI: possibilities and limitations in prevention].

Authors:  C U Herborn; F M Vogt; M Goyen; S C Goehde; S G Ruehm; M Forsting
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

Review 3.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

Review 4.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

Review 5.  Perspectives for preventive screening with total body MRI.

Authors:  Susanne C Ladd; Mark E Ladd
Journal:  Eur Radiol       Date:  2007-06-05       Impact factor: 5.315

6.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

Review 7.  Whole-Body MRA.

Authors:  Harald Kramer; Harald H Quick; Bernd Tombach; Stefan O Schoenberg; Joerg Barkhausen
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

8.  Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease.

Authors:  Mathias Goyen; Christoph U Herborn; Knut Kröger; Stefan G Ruehm; Jörg F Debatin
Journal:  Eur Radiol       Date:  2005-09-21       Impact factor: 5.315

Review 9.  [Oncologic screening with whole-body MRI: possibilities and limitations].

Authors:  J F Schäfer; A Fischmann; M Lichy; J Vollmar; M Fenchel; C D Claussen; H-P Schlemmer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

Review 10.  [Screening in cardiovascular diseases].

Authors:  H Kramer; S Weckbach; G van Kaick; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.